← Back to the chain

Recurance · prevention of future deaths reports

Pre-inquest brief

Inadequate adrenaline dose in autoinjectors

Organisation: Medicines and Healthcare products Regulatory Agency · Generated: 26 Oct 2026

Recurance · recurance.com/chains/5c0c724ca9a0d5ad

The earlier warning

Natasha Ednan-Laperouse · 8 Oct 2018 · Sean Cummings, London (West)

“The dose of adrenaline in Epipen is 300mcg. The UK Resuscitation Council recommends a standard emergency dose of 500mcg.”

judiciary.uk/…/natasha-ednan-laperouse

What was promised

Stated action 1 · response to Natasha Ednan-Laperouse (8 Oct 2018) · stated timescale: none stated

“manufacturers were required to disclose the exposed needle length of their adrenaline auto-injector devices in the product information to inform the healthcare professional and patient so they can take this in to account in deciding which device is appropriate for an individual patient”

judiciary.uk/…/2018-0279-Response-by-MHRA.pdf

What recurred

  • 27 Jan 2020 · Shanté Turay-Thomas · Mary Hassell · Identical hazard · confidence 0.95 (high)

The clearest link, quoted from both reports:

Earlier · Natasha Ednan-Laperouse · 8 Oct 2018

“The dose of adrenaline in Epipen is 300mcg. The UK Resuscitation Council recommends a standard emergency dose of 500mcg.”

Later · Shanté Turay-Thomas · 27 Jan 2020

“When [name redacted]'s AAI was changed from an EpiPen to an Emerade, her GPs failed to reconsider the prescription and to increase her dose from 300mgs to 500mcgs.”

What happened next

No web check of the stated actions has been published for this chain.

Every quote is verified word for word against the original report on judiciary.uk. A link shows that a similar concern was raised again, not why. It is not a finding about any organisation or person.

Source: Courts and Tribunals Judiciary, Open Government Licence v3.0.